(Q43991035)

28 November 2017

Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection (English)

1 reference

28 November 2017

0 references

Hull CK

1

1 reference

28 November 2017

Penman AD

series ordinal

2

1 reference

28 November 2017

Smith CK

series ordinal

3

1 reference

28 November 2017

Martin PD

series ordinal

4

1 reference

28 November 2017

1 June 2002

1 reference

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

28 November 2017

1 reference

28 November 2017

772

1 reference

28 November 2017

219-228

1 reference

28 November 2017

2

1 reference

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900088-0

7 January 2021

Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900088-0

7 January 2021

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900088-0

7 January 2021

Enzyme-linked immunosorbent assay of pravastatin, a HMG-CoA reductase inhibitor, in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900088-0

7 January 2021

Determination of pravastatin sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative ion chemical ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900088-0

7 January 2021

Quantitative determination of pravastatin and its biotransformation products in human serum by turbo ion spray LC/MS/MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900088-0

7 January 2021

Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900088-0

7 January 2021

Development, validation, and interlaboratory comparison of an HMG-CoA reductase inhibition assay for quantitation of atorvastatin in plasma matrices

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900088-0

7 January 2021

10.1016/S1570-0232(02)00088-0

Identifiers

DOI

1 reference

28 November 2017

1 reference